Literature DB >> 2877730

Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids.

E S Srivatsan, W F Benedict, E J Stanbridge.   

Abstract

Cytogenetic analyses of intraspecies human HeLa X fibroblast hybrid cell populations have provided tentative evidence for the correlation of loss of a single copy of chromosomes 11 and 14 with reexpression of tumorigenicity. In this study paired combinations of nontumorigenic and tumorigenic segregant HeLa X fibroblast hybrid cells from two independent fusion events were examined for the presence or absence of normal chromosomes 11 and 14. In human hybrid cell lines the parental origin of chromosomes can be distinguished on the basis of restriction fragment length polymorphisms. Genes for c-Ha-ras, insulin, and apolipoprotein A-1 on chromosome 11 and a polymorphic locus AW101 on chromosome 14 were used as Southern hybridization probes. Analysis of DNA from the parental fibroblast and HeLa cell lines and their nontumorigenic and tumorigenic hybrids showed the loss of a fibroblast chromosome 11 in four of the tumorigenic segregants and a HeLa chromosome 11 in a fifth hybrid cell line. This latter segregant has, interestingly, also lost a copy of chromosome 14 of fibroblast origin. There was no obvious correlation of loss of a copy of normal chromosome 14 and reexpression of tumorigenicity in any of the other hybrid cell populations. Our conclusion from these observations is that gene(s) that map to normal chromosome 11 might be involved in control of tumorigenic expression in these human hybrid cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877730

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Suppression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa X fibroblast hybrid cells.

Authors:  F X Bosch; E Schwarz; P Boukamp; N E Fusenig; D Bartsch; H zur Hausen
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression.

Authors:  J H Lichy; M Majidi; J Elbaum; M M Tsai
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

3.  Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.

Authors:  B C Misra; E S Srivatsan
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

Review 4.  Suppression of the neoplastic phenotype and "anti-oncogenes".

Authors:  R Schäfer
Journal:  Blut       Date:  1987-05

5.  Uncontrolled nuclear division in normal x transformed somatic cell hybrids.

Authors:  I Hickey; C McConville; M McMenamin; P Shirodaria
Journal:  Br J Cancer Suppl       Date:  1988-12

6.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Authors:  E S Srivatsan; B C Misra; M Venugopalan; S P Wilczynski
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

7.  The genomic and transcriptomic landscape of a HeLa cell line.

Authors:  Jonathan J M Landry; Paul Theodor Pyl; Tobias Rausch; Thomas Zichner; Manu M Tekkedil; Adrian M Stütz; Anna Jauch; Raeka S Aiyar; Gregoire Pau; Nicolas Delhomme; Julien Gagneur; Jan O Korbel; Wolfgang Huber; Lars M Steinmetz
Journal:  G3 (Bethesda)       Date:  2013-08-07       Impact factor: 3.154

8.  Transformation of human cells by oncogenic viruses supports permissiveness for parvovirus H-1 propagation.

Authors:  S Faisst; J R Schlehofer; H zur Hausen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Functional evidence for a second tumor suppressor gene on human chromosome 17.

Authors:  P Chen; N Ellmore; B E Weissman
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.

Authors:  K M Latham; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.